| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/30/1996 | US5541086 Method for the production of porcine growth hormone using a synthetic gene in yeast cells |
| 07/30/1996 | US5541085 Method for preparing orphan receptor ligands |
| 07/30/1996 | US5541084 Hybrid yeast promoter comprising an ENO2 UAS and TATA region and an additional UAS located between said ENO2 UAS and TATA region |
| 07/30/1996 | US5541083 Method for producing secretable glycosyltransferases and other golgi processing enzymes |
| 07/30/1996 | US5541078 Antigenic peptide sequence of echinococcus granulosus and diagnostic applications |
| 07/30/1996 | US5541077 Fungal stress proteins |
| 07/30/1996 | US5541068 Isolated and purified polypeptide encoded by messenger rna used to detect susceptibility of obesity |
| 07/30/1996 | US5541065 Amplifying nucleic acid sequence from exon two of human leukocyte antigen dpbeta gene in sample, mixing with panel of sequence specific oligonucleotide probes, detecting hybrids formed, determining genotype |
| 07/30/1996 | US5541063 Human interleukin-3 receptor α subunit |
| 07/30/1996 | US5540926 Gp39 protein |
| 07/30/1996 | US5540911 Methods of use of human manganese superoxide dismutase |
| 07/30/1996 | CA1338501C Method of detecting antibody against htlv-iii |
| 07/25/1996 | WO1996022393A1 Improved method of selecting specific bacteriophages |
| 07/25/1996 | WO1996022392A2 Nucleic acid amplification oligonucleotides and probes to lyme disease associated borrelia |
| 07/25/1996 | WO1996022391A1 Encoded reaction cassette |
| 07/25/1996 | WO1996022390A1 Methods, polypeptides, nucleotide sequence of xor-6, a vitamin d-like receptor from xenopus |
| 07/25/1996 | WO1996022389A1 Purified thermococcus barossii dna polymerase |
| 07/25/1996 | WO1996022388A1 Amplification of simple sequence repeats |
| 07/25/1996 | WO1996022386A1 A method for screening for inhibition of periplasmic oxidoreductase enzymes |
| 07/25/1996 | WO1996022384A1 Anti-cd 30 antibodies preventing proteolytic cleavage and release of membrane-bound cd 30 antigen |
| 07/25/1996 | WO1996022383A1 Spectroscopically detectable nucleic acid ligands |
| 07/25/1996 | WO1996022380A2 Method to improve screening efficiency in fused cells |
| 07/25/1996 | WO1996022379A2 Direct gene transfer into the ruminant mammary gland |
| 07/25/1996 | WO1996022378A1 Cells for the production of recombinant adenoviruses |
| 07/25/1996 | WO1996022377A1 Activation of t-cells by modified, antigenic immunoglobulins |
| 07/25/1996 | WO1996022376A1 Mutant luciferases |
| 07/25/1996 | WO1996022375A2 Procedures and materials for conferring disease resistance in plants |
| 07/25/1996 | WO1996022374A1 A new chemokine expressed in fetal spleen, its production and uses |
| 07/25/1996 | WO1996022372A2 Antibodies for the control of cyst nematodes and transgenic plants expressing them |
| 07/25/1996 | WO1996022371A2 C-C CHEMOKINE RECEPTOR 3: CKP-3 OR Eos-L2 |
| 07/25/1996 | WO1996022370A1 Human fas gene promoter region |
| 07/25/1996 | WO1996022369A1 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
| 07/25/1996 | WO1996022368A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 07/25/1996 | WO1996022367A1 Nucleic acid encoding a stress-responsive subunit of human rna polymerase ii |
| 07/25/1996 | WO1996022366A1 Transglutaminases from oomycetes |
| 07/25/1996 | WO1996022363A1 Recombinant swinepox virus |
| 07/25/1996 | WO1996022361A1 GENE ENCODING AN INVERTEBRATE α1CALCIUM CHANNEL SUBUNIT |
| 07/25/1996 | WO1996022360A1 Human prostatic specific reductase |
| 07/25/1996 | WO1996022307A1 Genes encoding an insect calcium channel |
| 07/25/1996 | WO1996022301A1 HETEROLOGOUS POLYPEPTIDE PRODUCTION IN THE ABSENCE OF NONSENSE-MEDIATED mRNA DECAY FUNCTION |
| 07/25/1996 | WO1996022299A1 Method for the purification of short nucleic acids |
| 07/25/1996 | WO1996022298A1 Method and composition for stabilization of labelled nucleoside triphosphates |
| 07/25/1996 | WO1996022112A1 Delivery of therapeutic agents by gene therapy |
| 07/25/1996 | WO1996022016A1 Transgenic plants and plant cells with enhanced pathogen resistance and related methods |
| 07/25/1996 | WO1996022015A1 Transgenic grasses |
| 07/25/1996 | WO1996012040A3 Compositions and methods for the detection of chlamydia trachomatis |
| 07/25/1996 | WO1996012021A3 Nematode-extracted serine protease inhibitors and anticoagulant proteins |
| 07/25/1996 | WO1996006177A3 Retrovirus-like particles made non-infectious by a plurality of mutations |
| 07/25/1996 | WO1996001320A3 Complete genomic sequence of autographa californica nuclear polyhedrosis virus C6 |
| 07/25/1996 | DE19501840A1 Desoxyribonukleinsäure und ihre Verwendung Deoxyribonucleic acid and their use |
| 07/25/1996 | CA2241977A1 Antibodies for the control of cyst nematodes and transgenic plants expressing them |
| 07/25/1996 | CA2210997A1 Activation of t-cells by modified, antigenic immunoglobulins |
| 07/25/1996 | CA2210986A1 Method to improve screening efficiency in fused cells |
| 07/25/1996 | CA2210897A1 Direct gene transfer into the ruminant mammary gland |
| 07/25/1996 | CA2210895A1 Purified thermococcus barossii dna polymerase |
| 07/25/1996 | CA2210855A1 Method for the purification of short nucleic acids |
| 07/25/1996 | CA2210718A1 Delivery of therapeutic agents by gene therapy |
| 07/25/1996 | CA2210713A1 Encoded reaction cassette |
| 07/25/1996 | CA2210679A1 Methods, polypeptides, nucleotide sequence of xor-6, a vitamin d-like receptor from xenopus |
| 07/25/1996 | CA2210618A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 07/25/1996 | CA2210567A1 Improved method of selecting specific bacteriophages |
| 07/25/1996 | CA2210560A1 Heterologous polypeptide production in the absence of nonsense-mediated mrna decay function |
| 07/25/1996 | CA2210526A1 Transgenic grasses |
| 07/25/1996 | CA2210521A1 Transgenic plants and plant cells with enhanced pathogen resistance and related methods |
| 07/25/1996 | CA2210440A1 Procedures and materials for conferring disease resistance in plants |
| 07/25/1996 | CA2210168A1 Cells for the production of recombinant adenoviruses |
| 07/25/1996 | CA2210158A1 Monoclonal antibody 1a7 and use for the treatment of melanoma and small cell carcinoma |
| 07/25/1996 | CA2208730A1 Transglutaminases from oomycetes |
| 07/25/1996 | CA2207086A1 G protein-coupled receptor gene |
| 07/25/1996 | CA2207009A1 A new chemokine expressed in fetal spleen, its production and uses |
| 07/24/1996 | EP0723019A1 A process for the production of biologically active peptide via the expression of modified storage seed protein genes in transgenic plants |
| 07/24/1996 | EP0723018A1 Expression vector for human topoisomerase I |
| 07/24/1996 | EP0723017A2 Transketolase |
| 07/24/1996 | EP0723016A2 Activating factor of leukocytes |
| 07/24/1996 | EP0723015A1 Novel modified PF4 compositions and methods of use |
| 07/24/1996 | EP0723014A2 cDNA of DOCK180 gene and DOCK180 protein |
| 07/24/1996 | EP0723013A2 Biosynthetic osteogenic proteins and osteogenic devices containing them |
| 07/24/1996 | EP0723012A1 Dna coding for phosphoenolpyruvate carboxykinase, recombinant vector containing the same, and transgenic plant |
| 07/24/1996 | EP0722951A2 Method and apparatus for the production of TGF-beta and purified TGF-beta compositions |
| 07/24/1996 | EP0722738A2 Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations |
| 07/24/1996 | EP0722566A1 A method for characterizing polymer molecules or the like |
| 07/24/1996 | EP0722508A1 Self-sustained sequence replication electrochemiluminescent nucleic acid assay |
| 07/24/1996 | EP0722507A1 Detection of amplified or deleted chromosomal regions |
| 07/24/1996 | EP0722506A1 Assay procedure and application in identification of herbicides |
| 07/24/1996 | EP0722504A1 Synthesis of adipic acid from biomass-derived carbon sources |
| 07/24/1996 | EP0722503A1 Lactic acid bacterial suppressor mutants and their use as selective markers and as means of containment in lactic acid bacteria |
| 07/24/1996 | EP0722502A1 Methods of increasing rates of infection by directing motion of vectors |
| 07/24/1996 | EP0722501A1 Cloned pullulanase |
| 07/24/1996 | EP0722500A1 Genes for butyrobetaine/crotonobetaine-l-carnitine metabolism and their use for the microbiological production of l-carine |
| 07/24/1996 | EP0722499A1 Immunoreactive antigens of hepatitis e virus |
| 07/24/1996 | EP0722498A1 Virus resistant or tolerant cells |
| 07/24/1996 | EP0722497A1 Dna spacer regulatory elements responsive to cytokines and methods for their use |
| 07/24/1996 | EP0722496A1 Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases |
| 07/24/1996 | EP0722495A1 A method for displaying proteins |
| 07/24/1996 | EP0722494A1 Transgenic plants that exhibit enhanced nitrogen assimilation |
| 07/24/1996 | EP0722493A1 Modified dna virus vectors and uses therefor |
| 07/24/1996 | EP0722490A1 Amylase variants |
| 07/24/1996 | EP0722489A1 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations |
| 07/24/1996 | EP0722488A1 Synthesis of catechol from biomass-derived carbon sources |
| 07/24/1996 | EP0722487A1 Direct molecular cloning of primer extended dna |